310 JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS REFERENCES (1) B. J. Poulsen, E. Young, V. Coquilla, and M. Katz, Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester, fl. Pharm. Sci., 57, 928-933 (1968). (2) J. Ostrenga, C. Steinmetz, and B. J. Poulsen, Significance of vehicle composition I: Relationship between topical vehicle composition, skin penetrability, and clinical efficacy, J. Pharm. Sci., 60, 1175-1179 (1971). (3) J. Ostrenga, J. Haleblian, B. J. Poulsen, B. Ferrell, N. Mueller, and S. Shastri, Vehicle design for a new topical steroid, fluocinonide, J. Invest. Derre., 56, 392-399 (1971). (4) J. S. Turi, D. Danielson, and J. W. Woltersom, Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate, fl. Pharm. Sci., 68, 275- 280 (1979). (5) C. W. Whitworth and L. D. Yantis, Ability of certain additives to influence the absorption of salicylic acid from solutions in an in vitro study: Preliminary Report, fl. Pharm. Sci., 56, 1161-1163 (1967). (6) B. Pormoy, The effect of formulation on the clinical response to topical fluocinolone acetonide, Br. J. Dermatol., 77, 579-581 (1965). (7) C. W. Barrett, J. W. Hadgraft, G. A. Caron and I. Sarknay, The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide, Br. J. Dermatol., 77, 576-578 (1965). (8) M. Ponec, Penetration of corticosteroids through the skin in relation to the vehicle, Dermatologica, 152 (Suppl. 1), 37-46 (1976). (9) M. K. Polano and M. Ponec, Dependence of corticosteroid penetration on the vehicle, Arch. Der- matol., 112, 675-680 (1976). (10) R. J. Feldmann and H. I. Maibach, Percutaneous penetration of •4C hydrocortisone in man, Arch. Dermatol., 94, 649-651 (1966). (11) R. N. Brogden, T. M. Speight, and G. S. Avery, Fluocinonide in FAPG base: A review of its therapeutic efficacy in inflammatory dermatoses, Drugs, 7, 337-343 (1974). (12) I. I. Lubowe, Scalp dermatoses: Treatment with fluocinolone acetonide in propylene glycol, Skin, 3, 267-269 (1964). (13) M. Henry, Clinical trial of fluocinolone acetonide in FAPG base in the treatment of varicose eczema, Curr. Ned. Res. Opin., 2, 27-31 (1974). (14) S. M. Bluefarb, F. M. Howard, and E. Leibsohn, Diflorasone diacetate: Vasoconstrictor activity and clinical efficacy of a new topical corticosteroid, J. Int. Ned. Res., 4, 454-461 (1976). (15) R. Woodford and B. W. Barry, The placebo response to white soft-paraffin/propylene glycol in the skin blanching test, Br. J. Dermatol., 89, 53-59 (1973). (16) M. Hannuksela, V. Pirila, and O. P. Salo, Skin reactions to propylene glycol, Contact Dermatitis, 1, 112-116 (1975). (17) M. Hannuksela, M. Kousa, and V. Pirila, Allergy to ingredients of vehicles, Contact Dermatitis, 2, 105-110 (1976). (18) R. J. Trarrick and H. I. Maibach, Propylene glycol: Irritation or sensitization?, Contact Dermatitis, 1, 112-116 (1975). (19) T. G. Warshaw and F. Hermann, Studies of skin reactions to propylene glycol, J. Invest. Dermatol., 19, 423-430 (1952). (20) R. H. Shore and W. B. Shelley, Contact dermatitis from stearyl alcohol and propylene glycol in fluocinonide cream, Arch. Dermatol., 109, 397-402 (1974). (21) J. A. Oleffe, A. Blondeel, and A. deCorinck, Allergy to chlorocresol and propylene glycol in asteroid cream, Contact Dermatitis, 5, 53-54 (1979). (22) R. S. Medansky, R. M. Handler, and W. Cook, A trial with fluocinonide in recalcitrant dermatoses, Int. J. Dermatol., 18, 83-88 (1979). (23) J.P. Nater, A. J. M. Baar, and P. J. Hoedemaeker, Histological aspects of skin reactions to pro- pylene glycol, Contact Dermatitis, 3, 181-185 (1977). (24) A. A. Fisher, Dermatologic hazards of electrocardiography, Cutis, 20, 686-695 (1977). (25) A. A. Fisher, Dermatitis associated with transcutaneous electrical nerve stimulations, Cutis, 21, 24- 33 (1978). (26) A. A. Fisher and R. R. Brancaccio, Allergic contact sensitivity to propylene glycol in a lubricant jelly, Arch. Dermatol., 115, 1451 (1979). (27) S. Agren-Jonsson and B. Magnussun, Sensitization to propanthiline bromide, trichlorocarbanilide and propylene glycol in an anti-perspirant, Contact Dermatitis, 2, 79-80 (1976).

COMPARISON OF TOPICAL VEHICLES 311 (28) P. J. Frosch and A.M. Kligman, "The Chamber-Scarification Test for Assessing Irritancy of Topi- cally Applied Substances," in Cuta,eous Toxicity, V. A. Drill and P. Lazar., Eds. (Academic Press, New York, 1977) pp 127-154. (29) Technical Bulletin, Kay-Fries, Inc., Rockleigh, NJ. (30) Technical Bulletin, Henkel, Hoboken, NJ. (31) T. Higuchi, Physical chemical analysis ofpercutaneous absorption process from creams and ointments, J. Soc. Cosmet. Chem., 11, 85-97 (1960). (32) A. W. McKenzie and R. B. Stoughton, Method for comparing percutaneous absorption of steroids, Arch. Dermato/., 86, 608 (1962). (33) L. Phillips, M. Steinberg, H. I. Maibach, and W. A. Akers, A comparison of rabbit and human skin response to certain irritants, Toxicol. Appl. Pharmacol., 21, 369-382 (1972).